Drug profile · INN
formoterol
FORADILE
formoterol (FORADILE) is a beta-2 adrenergic receptor agonist. Associated with AstraZeneca.
EMA: approved TGA: approved Respiratory system (R03) R03AL
Patents linked 0
Pipeline programs 24
News articles 0
Drug details — formoterol
- Class
- Respiratory system (R03)
- Route
- —
- Patents
- 0
- Programs
- 24
- Data quality
- 0.83
Quick answer
formoterol (FORADILE) is a beta-2 adrenergic receptor agonist. Associated with AstraZeneca.
Key facts
INN formoterol
Brand FORADILE
Mechanism Beta-2 adrenergic receptor agonist
Therapeutic class Respiratory system (R03)
ATC code R03AL
Originator AstraZeneca
Mechanism of action
Beta-2 adrenergic receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
- Aclidinium bromide/formoterol Fixed-Dose Combination
- Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
- Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX
- Budesonide/Formoterol SPIROMAX®
- Budesonide/Formoterol fumarate dihydrate
- Budesonide/formoterol Turbuhaler
- D5982C00007
- D5982C00008
Related & competitor drugs
Frequently asked questions
What is formoterol?
formoterol (FORADILE) is a beta-2 adrenergic receptor agonist. Associated with AstraZeneca.
What is the brand name for formoterol?
FORADILE is a marketed brand name for formoterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.